D
Drugs Made In America Acquisition II Corp. — Investor Relations & Filings
Filings indexed
31
across all filing types
Latest filing
2026-04-28
Regulatory Filings
Country
US
United States of America
Listing
US
DMIIU
Drugs Made In America Acquisition II Corp. is a blank check company, also known as a special purpose acquisition company (SPAC). It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company intends to focus its search for a business combination target within the pharmaceutical industry.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - Drugs Made In America Acquisition II Corp. (0002040475) (Filer) | 2026-04-28 | English | |
| 10-K - Drugs Made In America Acquisition II Corp. (0002040475) (Filer) | 2026-04-15 | English | |
| 8-K - Drugs Made In America Acquisition II Corp. (0002040475) (Filer) | 2026-04-03 | English | |
| QUARTERLY REPORT | 2025-11-18 | English | |
| CURRENT REPORT | 2025-11-17 | English | |
| NOTIFICATION OF LATE FILING | 2025-11-14 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
3 filings
| |||||
| 38191773 | 8-K - Drugs Made In America Acquisition II Corp. (0002040475) (Filer) | 2026-04-28 | English | ||
| 34607228 | 10-K - Drugs Made In America Acquisition II Corp. (0002040475) (Filer) | 2026-04-15 | English | ||
| 33302543 | 8-K - Drugs Made In America Acquisition II Corp. (0002040475) (Filer) | 2026-04-03 | English | ||
|
2025
12 filings
| |||||
| 13718380 | QUARTERLY REPORT | 2025-11-18 | English | ||
| 13718383 | CURRENT REPORT | 2025-11-17 | English | ||
| 13718381 | NOTIFICATION OF LATE FILING | 2025-11-14 | English | ||
| 13718382 | Director's Dealing 2025 | 2025-10-17 | English | ||
| 13718384 | CURRENT REPORT | 2025-10-02 | English | ||
| 13718385 | Director's Dealing 2025 | 2025-10-02 | English | ||
| 13718386 | Major Shareholding Notification 2025 | 2025-10-02 | English | ||
| 13718387 | Director's Dealing 2025 | 2025-10-01 | English | ||
| 13718388 | Director's Dealing 2025 | 2025-10-01 | English | ||
| 13718389 | Director's Dealing 2025 | 2025-10-01 | English | ||
| 13718390 | Director's Dealing 2025 | 2025-10-01 | English | ||
| 13718391 | CURRENT REPORT | 2025-09-29 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Activities of non-money market investments funds
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ABRDN AUSTRALIA EQUITY FUND, INC.
A closed-end fund seeking capital appreciation by investing…
|
IAF | US | Financial and insurance activit… |
|
abrdn Diversified Income and Growth plc
An investment trust in a managed wind-down, realizing asset…
|
ADIG | GB | Financial and insurance activit… |
|
abrdn Emerging Markets ex-China Fund, Inc.
A closed-ended fund investing in emerging market equities, …
|
AEF | US | Financial and insurance activit… |
|
abrdn Equity Income Trust plc
Investment trust providing income and long-term growth from…
|
AEI | GB | Financial and insurance activit… |
|
abrdn Global Dynamic Dividend Fund
A closed-end fund seeking high dividend income from a globa…
|
AGD | US | Financial and insurance activit… |
|
ABRDN GLOBAL INCOME FUND, INC.
A closed-end fund investing in global fixed-income securiti…
|
FCO | US | Financial and insurance activit… |
|
abrdn Global Infrastructure Income Fund
A closed-end fund investing in global infrastructure for in…
|
ASGI | US | Financial and insurance activit… |
|
abrdn Global Premier Properties Fund
A closed-end fund investing globally in real estate equitie…
|
AWP | US | Financial and insurance activit… |
|
abrdn Gold ETF Trust
Issues an ETF whose shares reflect the performance of gold …
|
SGOL | US | Financial and insurance activit… |
|
abrdn Healthcare Investors
Closed-ended fund investing in global healthcare, focusing …
|
HQH | US | Financial and insurance activit… |
Drugs Made In America Acquisition II Corp. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35620/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35620 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35620 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35620 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35620}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Drugs Made In America Acquisition II Corp. (id: 35620)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.